Editorial Commentary
Will phenotype help guide immunotherapy in prostate cancer?
Translational Cancer Research
2025;
14
(4)
:2170-2174
.
(30 April 2025)
Still thirsting for a fix
Translational Cancer Research
2025;
14
(4)
:2175-2177
.
(30 April 2025)
Liquid biopsy in advanced and metastatic breast cancer: translating prognostic value to clinical implementation
Translational Cancer Research
2025;
14
(4)
:2178-2182
.
(30 April 2025)
Exploiting pre-dormancy tumor immune microenvironment induced by androgen deprivation in prostate cancer
Translational Cancer Research
2025;
14
(4)
:2183-2187
.
(30 April 2025)
Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations
Translational Cancer Research
2025;
14
(4)
:2188-2191
.
(30 April 2025)
Original Article
Investigating additional malignancy rates and prognostic factors in multiple myeloma patients: a Surveillance, Epidemiology, and End Results (SEER) database retrospective cohort study
Translational Cancer Research
2025;
14
(4)
:2192-2206
.
(30 April 2025)
Association between blood metal elements and lung cancer: a cross-sectional and Mendelian randomization study
Translational Cancer Research
2025;
14
(4)
:2207-2219
.
(30 April 2025)
Characteristics and clinical outcomes of early-onset gastrointestinal stromal tumors: a population-based study
Translational Cancer Research
2025;
14
(4)
:2220-2232
.
(30 April 2025)
Development and validation of predictive nomograms for survival in early-onset colon cancer patients with II–III stage across various tumor sites
Translational Cancer Research
2025;
14
(4)
:2233-2249
.
(30 April 2025)
Spectral computed tomography iodine concentration spatial distribution and multi-parameter quantitative analysis in the differential diagnosis of central small cell lung cancer from squamous cell carcinoma
Translational Cancer Research
2025;
14
(4)
:2250-2259
.
(30 April 2025)
YWHAE affects proliferation, migration and apoptosis of colorectal cancer by regulating extracellular vesicles secretion and Wnt/β-catenin signaling pathway
Translational Cancer Research
2025;
14
(4)
:2260-2273
.
(30 April 2025)
Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration
Translational Cancer Research
2025;
14
(4)
:2274-2289
.
(30 April 2025)
Comparison of chemoport and Hickman central venous catheters in patients with hematological cancer
Translational Cancer Research
2025;
14
(4)
:2290-2302
.
(30 April 2025)
CDKN2A as a prognostic and diagnostic marker is a possible key contributor in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(4)
:2303-2318
.
(30 April 2025)
Prognostic significance of chemotherapy response score in predicting outcomes for high-grade serous ovarian carcinoma patients undergoing neoadjuvant chemotherapy
Translational Cancer Research
2025;
14
(4)
:2319-2330
.
(30 April 2025)
High-frequency KRAS mutations in pancreatic adenocarcinoma: prognostic significance and potential co-targeting therapies
Translational Cancer Research
2025;
14
(4)
:2331-2342
.
(30 April 2025)
Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database
Translational Cancer Research
2025;
14
(4)
:2343-2353
.
(30 April 2025)
Increased risk of colorectal adenoma and benign colorectal polyp associated with Helicobacter pylori infection: a systematic review and meta-analysis
Translational Cancer Research
2025;
14
(4)
:2354-2366
.
(30 April 2025)
Development and validation of survival prediction nomograms for patients with early-stage rectal cancer: a population-based study
Translational Cancer Research
2025;
14
(4)
:2367-2380
.
(30 April 2025)
Elevated levels of total cholesterol and high-density lipoprotein cholesterol are associated with better prognosis in patients with lung adenocarcinoma: a retrospective cohort study
Translational Cancer Research
2025;
14
(4)
:2381-2394
.
(30 April 2025)
scRNA-seq reveals chemotherapy-induced tumor microenvironment changes in pancreatic ductal adenocarcinoma
Translational Cancer Research
2025;
14
(4)
:2395-2409
.
(30 April 2025)
Efficacy of three lung cancer prediction models in diagnosing benign and malignant pulmonary nodules
Translational Cancer Research
2025;
14
(4)
:2410-2420
.
(30 April 2025)
Single-cell RNA sequencing for characterizing the immune communication and iron metabolism roles in CD31+ glioma cells
Translational Cancer Research
2025;
14
(4)
:2421-2439
.
(30 April 2025)
FXR activation suppresses NF-κB signaling, proliferation and migration in cervical cancer cells
Translational Cancer Research
2025;
14
(4)
:2440-2456
.
(30 April 2025)
Role of TRKC and NT-3 proteins in the progression and prognosis of colorectal cancer
Translational Cancer Research
2025;
14
(4)
:2457-2469
.
(30 April 2025)
Preliminary study of apatinib combined with fluzoparib in the treatment of HRP ovarian cancer via the HR pathway
Translational Cancer Research
2025;
14
(4)
:2470-2482
.
(30 April 2025)
Effect and mechanism of the miR-1284/EIF4A1 axis on the cGAS-STING pathway under radiotherapy
Translational Cancer Research
2025;
14
(4)
:2483-2494
.
(30 April 2025)
Review Article
From induced pluripotent stem cell (iPSC) to universal immune cells: literature review of advances in a new generation of tumor therapies
Translational Cancer Research
2025;
14
(4)
:2495-2507
.
(30 April 2025)
Artificial intelligence radiomics in the diagnosis, treatment, and prognosis of gynecological cancer: a literature review
Translational Cancer Research
2025;
14
(4)
:2508-2532
.
(30 April 2025)
Erratum
Erratum: FTO-mediated m6A demethylation of SERPINE1 mRNA promotes tumor progression in hypopharyngeal squamous cell carcinoma
Translational Cancer Research
2025;
14
(4)
:2533-2535
.
(30 April 2025)
